The global Integrase Inhibitors Market is estimated to be valued at US$ 29.34 billion in 2023 and is expected to exhibit a CAGR of 3.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:Integrase inhibitors are a class of antiretroviral drugs used in the treatment of HIV infection. These inhibitors prevent the integration...